Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progress and challenges for cell encapsulation in brain tumour therapy.

Therese Visted1, Morten Lund-Johansen

  • 1Molecular Neuro-Oncology Laboratories, Neurosugery Service, Massachusetts General Hospital-East, Harvard Medical School, 149 13th Street, PO Box 57, Charlestown, MA 02129, USA. tvisted@partners.org

Expert Opinion on Biological Therapy
|July 2, 2003
PubMed
Summary

Cell encapsulation shields therapeutic cells from immune rejection, offering a novel approach for localized cancer treatment. This technology shows promise for delivering anti-cancer proteins to brain tumors like glioblastoma multiforme (GBM).

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical management of vestibular schwannoma - what's the evidence?

Acta neurochirurgica·2026
Same author

Steroid-dependent metabolic rewiring reveals novel therapeutic and imaging approaches for glioblastoma.

Science advances·2026
Same author

Quality of life after treatment of vestibular schwannomas.

Handbook of clinical neurology·2025
Same author

Cushing's disease in Western Norway Regional Health Authority.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2025
Same author

[Vestibular schwannoma – diagnostics and treatment].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2025
Same author

Optimal Timing of Primary Radiosurgical Treatment of Growing Vestibular Schwannoma: Insights From Salvage Microsurgery Outcomes.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·2025

Area of Science:

  • Biotechnology
  • Immunology
  • Oncology

Background:

  • Cell encapsulation utilizes semipermeable membranes to shield implanted cells from the host immune system.
  • This technology aims to develop transplantable bio-organs without immunosuppression and offers potential in cancer therapy.
  • Malignant brain tumors, such as glioblastoma multiforme (GBM), are aggressive and largely unresponsive to current treatments.

Purpose of the Study:

  • To review recent advancements in cell encapsulation technology for therapeutic applications.
  • To discuss the potential of cell encapsulation for localized delivery of anti-cancer proteins to brain tumors.
  • To highlight challenges hindering the clinical translation of cell encapsulation for brain tumor patients.

Main Methods:

  • Review of scientific literature on cell encapsulation techniques and their applications.

Related Experiment Videos

  • Analysis of studies investigating encapsulated cells as bioreactors for therapeutic protein production.
  • Examination of preclinical data, including studies in animal models of glioma.

    • Main Results:

    • Cell encapsulation enables localized, long-term delivery of therapeutic proteins by using encapsulated cells as 'bioreactors'.
    • Preclinical studies in rats with gliomas demonstrated encouraging results using endostatin-secreting encapsulated cells.
    • Gene therapy trials for glioma have yielded disappointing results, highlighting the need for alternative approaches.

    Conclusions:

    • Cell encapsulation presents a promising alternative strategy for localized therapy in glioma patients.
    • The technology has not yet advanced to clinical trials but shows significant preclinical potential.
    • Further research is required to overcome challenges before clinical application in brain tumor patients.